CenterBook Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,530
| Closed | -$450K | – | 548 |
|
|
2024
Q3 | $450K | Sell |
11,530
-23,355
| -67% | -$911K | 0.03% | 399 |
|
|
2024
Q2 | $1.19M | Sell |
34,885
-87,572
| -72% | -$2.99M | 0.07% | 319 |
|
|
2024
Q1 | $3.08M | Buy |
122,457
+70,620
| +136% | +$1.77M | 0.21% | 179 |
|
|
2023
Q4 | $1.53M | Buy |
51,837
+36,699
| +242% | +$1.08M | 0.19% | 183 |
|
|
2023
Q3 | $478K | Sell |
15,138
-12,984
| -46% | -$410K | 0.06% | 338 |
|
|
2023
Q2 | $728K | Sell |
28,122
-26,231
| -48% | -$679K | 0.09% | 284 |
|
|
2023
Q1 | $1.31M | Sell |
54,353
-111
| -0.2% | -$2.67K | 0.18% | 179 |
|
|
2022
Q4 | $1.06M | Buy |
+54,464
| New | +$1.06M | 0.17% | 189 |
|
|
2022
Q3 | – | Sell |
-14,659
| Closed | -$285K | – | 424 |
|
|
2022
Q2 | $285K | Sell |
14,659
-3,737
| -20% | -$72.7K | 0.06% | 332 |
|
|
2022
Q1 | $405K | Buy |
18,396
+1,651
| +10% | +$36.3K | 0.14% | 237 |
|
|
2021
Q4 | $267K | Buy |
+16,745
| New | +$267K | 0.16% | 218 |
|